Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyActive Not Recruiting
Sponsor: Biohaven Therapeutics Ltd.
Focal Epilepsy
United States, Australia, Denmark, Finland, Germany +11 more
- Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockNot Yet Recruiting
Sponsor: Leipzig Heart Science gGmbH
Cardiogenic Shock · Acute Myocardial Infarction (AMI) · Heart Failure, Acute
Germany
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Enrolling By Invitation
Sponsor: Sanofi
Wheezing · Asthma
United States, Argentina, Brazil, Canada, Czechia +11 more
Sponsor: Viridian Therapeutics, Inc.
Thyroid Eye Disease
United States, Australia, France, Germany, Hungary +4 more
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Denmark, France, Germany, Spain
- Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease PatientsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Sickle Cell Disease (SCD)
United States, Belgium, Brazil, Canada, Colombia +16 more
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Argentina, China, Dominican Republic, Finland +18 more
Sponsor: Bundeswehr University Munich
Post-Traumatic Stress Disorder, PTSD
Germany
- PulseSelect™ PFA Global RegistryRecruiting
Sponsor: Medtronic Cardiac Ablation Solutions
Atrial Fibrillation
Belgium, Canada, China, Croatia, France +10 more
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
United States, Argentina, Austria, Belgium, Bulgaria +14 more
- The PERSEVERE StudyRecruiting
Sponsor: Inari Medical
Pulmonary Embolism · Pulmonary Thromboembolism
United States, France, Germany, Spain, Switzerland +1 more
- Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) SeizuresActive Not Recruiting
Sponsor: SK Life Science, Inc.
Partial Epilepsy
United States, Australia, Germany, Hungary, Poland +2 more
Sponsor: Merck Sharp & Dohme LLC
Metastatic Castration-resistant Prostate Cancer (mCRPC) · Prostatic Neoplasms
United States, Australia, Brazil, Canada, Chile +34 more
Sponsor: Novo Nordisk A/S
Type 2 Diabetes (T2D)
United States, Bulgaria, Croatia, Germany, Greece +6 more
Sponsor: BioNTech SE
Non-small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Bulgaria +15 more
- Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRecruiting
Sponsor: AstraZeneca
B-cell Non-Hodgkin Lymphoma · Follicular Lymphoma (FL) · Large B-Cell Lymphoma (LBCL)
United States, Australia, Brazil, Canada, China +11 more
- Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisRecruiting
Sponsor: Regeneron Pharmaceuticals
Lupus Nephritis (LN)
United States, France, Germany, South Korea, Spain +1 more
- An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRecruiting
Sponsor: AstraZeneca
Hyperkalaemia
United States, Brazil, Canada, China, Germany +8 more
- VITUS Post-Market RegistryActive Not Recruiting
Sponsor: OrbusNeich
Peripheral Arterial Disease · Peripheral Arterial Occlusive Disease
Belgium, Germany, Singapore, Spain
Sponsor: AstraZeneca
Endometrial Cancer · Gastric Cancer · Metastatic Castration-resistant Prostate Cancer · Ovarian Cancer
United States, Canada, China, France, Germany +9 more
- WATCHMAN FLX Pro European RegistryRecruiting
Sponsor: Boston Scientific Corporation
Non-valvular Atrial Fibrillation (AF) · Left Atrial Appendage Closure
Denmark, Germany, Italy, Poland, Spain +1 more
Sponsor: Viridian Therapeutics, Inc.
Thyroid Eye Disease
United States, Australia, France, Germany, Poland +2 more
Sponsor: Guerbet
Steno-occlusive Disease
United States, Canada, Czechia, France, Germany +5 more
- ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsActive Not Recruiting
Sponsor: OncoC4, Inc.
Non Small Cell Lung Cancer
United States, Australia, Belgium, Canada, China +7 more
- The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential ThrombocythemiaActive Not Recruiting
Sponsor: RWTH Aachen University
Polycythemia Vera (PV) · Essential Thrombocythemia (ET)
Germany